Drug Database
Back to search

Poland· PL-100119666

AntyGrypin

A acetylsalicylsäure, kombinationen, exkl. psycholeptika product containing acidum acetylsalicylicum + acidum ascorbicum + coffeinum, registered in Poland by N.P. Pharma Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC N02BA51

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAntyGrypinATCN02BA51REGISTER NO.PL-100119666PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acidum acetylsalicylicum + acidum ascorbicum + coffeinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acetylsalicylsäure, kombinationen, exkl. psycholeptika is registered in 9 of 19 countries.

Countries holding a registration under ATC N02BA51 (acetylsalicylsäure, kombinationen, exkl. psycholeptika), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search acetylsalicylsäure, kombinationen, exkl. psycholeptika products by name

Acetylsalicylsäure, kombinationen, exkl. psycholeptika · ATC N02BA51

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acetylsalicylsäure, kombinationen, exkl. psycholeptika costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acetylsalicylsäure, kombinationen, exkl. psycholeptika · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • FI Finland$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Acidum acetylsalicylicum + Acidum ascorbicum + Coffeinum
Manufacturer
N.P. Pharma Sp. z o.o.
Country
Poland (PL)
ATC code
N02BA51
ATC class
Acetylsalicylsäure, Kombinationen, exkl. Psycholeptika
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991024819
  • gtin
    05909991024826

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

47 interactions on record for acetylsalicylsäure, kombinationen, exkl. psycholeptika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acetylsalicylsäure, kombinationen, exkl. psycholeptika against other medicinesHow interaction checks work

Acetylsalicylsäure, kombinationen, exkl. psycholeptika · interactions on record

47 records

47 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Acetylsalicylsäure, kombinationen, exkl. psycholeptika in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acetylsalicylsäure, kombinationen, exkl. psycholeptika products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Togal Kopfschmerz-Brause
  • Finland · Finrexin Eukalyptus & Mentoli, Finrexin Mustaherukka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f98bfbdf-f9fd-4d93-922c-ede731d1ee1b
GET /v1/drugs/f98bfbdf-f9fd-4d93-922c-ede731d1ee1b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki musujące",
  "source": "urpl",
  "strength": "500 mg + 150 mg + 50 mg",
  "packaging": "05909991024819 ¦ OTC ¦ 22302\n10 tabl.\n05909991024826 ¦ OTC ¦ 22303\n20 tabl.",
  "substance": "Acidum acetylsalicylicum 500 mg + Acidum ascorbicum 150 mg + Coffeinum 50 mg",
  "common_name": "Acidum acetylsalicylicum + Acidum ascorbicum + Coffeinum",
  "pl_product_id": "100119666",
  "pozwolenie_nr": "10248",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about acetylsalicylsäure, kombinationen, exkl. psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console